iTeos Therapeutics
ITOS
#5001
Rank
$0.77 B
Marketcap
$21.70
Share price
-2.47%
Change (1 day)
-38.58%
Change (1 year)

Operating Margin for iTeos Therapeutics (ITOS)

Operating Margin as of January 2023 (TTM): 71.61%

According to iTeos Therapeutics's latest financial reports and stock price the company's current Operating Margin is 71.61%. At the end of 2021 the company had an Operating Margin of 74.39%.

Operating Margin history for iTeos Therapeutics from 2022 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
202174.39%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
0.00%-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.